We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+10.69%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$377M
AUM Growth
+$38.3M
Cap. Flow
+$4.65M
Cap. Flow %
1.23%
Top 10 Hldgs %
27.08%
Holding
117
New
3
Increased
49
Reduced
25
Closed
3

Top Sells

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$516K
2
MSFT icon
Microsoft
MSFT
+$494K
3
MDT icon
Medtronic
MDT
+$489K
4
HYD icon
VanEck High Yield Muni ETF
HYD
+$446K
5
VZ icon
Verizon
VZ
+$318K

Sector Composition

Rank Sector Weight
1 Technology 14.86%
2 Healthcare 13.19%
3 Consumer Staples 10.73%
4 Industrials 10.66%
5 Consumer Discretionary 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
51
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$3.39M 0.9%
7,130
-13
-0.2% -$5.79K
CTAS icon
52
Cintas
CTAS
$81.6B
$3.33M 0.88%
22,120
HD icon
53
Home Depot
HD
$339B
$3.22M 0.85%
9,285
-9
-0.1% -$2.79K
MGA icon
54
Magna International
MGA
$18.2B
$3.2M 0.85%
54,185
+205
+0.4% +$11.1K
VTI icon
55
Vanguard Morningstar Total Stock Market ETF
VTI
$670B
$2.94M 0.78%
12,380
IJH icon
56
iShares Core S&P Mid-Cap ETF
IJH
$124B
$2.8M 0.74%
50,460
+255
+0.5% +$12.9K
HYG icon
57
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.66M 0.71%
34,387
+6,231
+22% +$465K
LLY icon
58
Eli Lilly
LLY
$1,000B
$2.58M 0.69%
4,433
VB icon
59
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$2.33M 0.62%
10,939
-246
-2% -$47.4K
BBH icon
60
VanEck Biotech ETF
BBH
$398M
$2.1M 0.56%
12,721
IAU icon
61
iShares Gold Trust
IAU
$62.9B
$2.06M 0.55%
52,753
IBB icon
62
iShares Biotechnology ETF
IBB
$9.18B
$2.04M 0.54%
15,056
-1,210
-7% -$148K
GOOG icon
63
Alphabet (Google) Class C
GOOG
$4.56T
$1.62M 0.43%
11,475
-345
-3% -$46.8K
JNJ icon
64
Johnson & Johnson
JNJ
$613B
$1.52M 0.4%
9,711
CVX icon
65
Chevron
CVX
$385B
$1.31M 0.35%
8,808
SYK icon
66
Stryker
SYK
$131B
$1.3M 0.35%
4,354
DIA icon
67
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.7B
$1.27M 0.34%
3,360
+2,650
+373% +$926K
VEU icon
68
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$1.2M 0.32%
21,403
-715
-3% -$37.9K
HYD icon
69
VanEck High Yield Muni ETF
HYD
$4.42B
$1.18M 0.31%
22,768
-8,998
-28% -$446K
ORCL icon
70
Oracle
ORCL
$409B
$1.09M 0.29%
10,319
VEA icon
71
Vanguard FTSE Developed Markets ETF
VEA
$230B
$1.05M 0.28%
21,999
CAT icon
72
Caterpillar
CAT
$382B
$1.05M 0.28%
3,542
PAYX icon
73
Paychex
PAYX
$41.9B
$907K 0.24%
7,615
FTRE icon
74
Fortrea Holdings
FTRE
$1.8B
$755K 0.2%
21,658
-717
-3% -$21.9K
IBM icon
75
IBM
IBM
$213B
$752K 0.2%
4,603

Similar funds

Boston Research & Management's Q4 2023 Portfolio in Review

As of Q4 2023, Boston Research & Management held 117 positions worth $377M, up 11% from $338M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Research & Management's Q4 2023 filing shows 3 new, 49 increased, 25 reduced and 3 closed positions. Its largest new stake was General Dynamics: 840 shares worth $218K. The largest sale was Fastenal, an estimated $516K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boston Research & Management's largest Q4 2023 buy was General Dynamics: 840 shares worth $218K.
  • Boston Research & Management added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2023, an estimated $926K increase.
  • Boston Research & Management's biggest Q4 2023 reduction was Fastenal, cutting an estimated $516K.
  • Boston Research & Management fully exited Yum China in Q4 2023, selling an estimated $240K.
  • Boston Research & Management's ten largest holdings make up 27% of its $377M portfolio in Q4 2023.
  • Boston Research & Management opened 3 new positions and closed 3 in Q4 2023.
  • Boston Research & Management's portfolio value rose 11% quarter-over-quarter to $377M.

Based on Boston Research & Management's 13F filing for Q4 2023, filed 12 Feb 2024.